SCHEMBL7646351

SCHEMBL7646351

CCC(C)OP(=O)(O)c1cc2cc(S(=O)(=O)Nc3ccccc3)c(Cl)cc2[nH]c1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WDR5 P61964 1/20 0.39
EGLN1 Q9GZT9 1/20 0.38
MAPT P10636 4/20 0.37
LMNA P02545 4/20 0.36
PGR P06401 1/20 0.36
POLB P06746 2/20 0.35
BRD4 O60885 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
TP53 P04637 1/20 0.34
THRB P10828 2/20 0.33
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
GRIK1 P39086 1/20 0.33
GRIA1 P42261 1/20 0.33
GRIA2 P42262 1/20 0.33
GRIA3 P42263 1/20 0.33
GRIA4 P48058 1/20 0.33
GRIN1 Q05586 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7647210 0.88 GRIN2D (0.38) LMNAGRIN2DGRIN3BGRIK1GRIA1
SCHEMBL7647196 0.87 KMT2A (0.33) KMT2ATP53GRIN2DGRIN3BGRIA1
SCHEMBL7648022 0.87 GRIN1 (0.32) TP53GRIN2DGRIN3BGRIA1GRIA2
SCHEMBL7652294 0.86 ALDH1A1 (0.42) MAPTLMNAPOLBSMN1; SMN2MEN1
SCHEMBL7648074 0.86 CA12 (0.32) MAPTLMNAGRIN2DGRIN3BGRIK1
SCHEMBL7645899 0.86 BCAT1 (0.37)
SCHEMBL7645912 0.86 GSTO1 (0.34) PGRGRIN2DGRIN3BGRIA1GRIA2
SCHEMBL7647655 0.86 ATM (0.34) POLBMEN1KMT2AGRIN2DGRIN3B
SCHEMBL7646330 0.85 GRIN1 (0.31) GRIN2DGRIN3BGRIA1GRIA2GRIA3
SCHEMBL7647833 0.85 POLB (0.33) LMNAPOLBSMN1; SMN2TP53GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6486143-B2 NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS LES LABORATOIRES SERVIER (FR) 2002-11-26 US disclosed
US-20010031746-A1 6-amino- or 6-hydrazino-sulphonyl-3-quinolynyl-phosphonic acid compounds LES LABORATOIRES SERVIER (FR) 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031746-A1 6-amino- or 6-hydrazino-sulphonyl-3-quinolynyl-phosphonic acid compounds CA6, P2RY6, FPR3 WDR5 3966/4885EGLN1 3787/4885MAPT 4631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.